CytoSorbents Corporation

(CTSO) Trade

By |

Profile

CytoSorbents Corp is a critical care immunotherapy leader commercializing its European Union approved CytoSorb blood purification technology to treat deadly inflammation in critically ill and cardiac surgery patients in around 55 countries.The Company is conducting its pivotal REFRESH 2 - AKI cardiac surgery trial, designed to support U.S. FDA approval. The company's product portfolio consists of CytoSorb, ContrastSorb, VetResQ, HemoDefend, K ontrol, and DrugSorb. The company has around 19 issued U.S. patents, multiple patents issued internationally, and a broad patent application portfolio pending.

Contact Information

Website: www.cytosorbents.com
Email: avogel@cytosorbents.com
Main Phone: +1 732 329-8885
Address: 7 Deer Park Drive
Address 2: Suite K
State: NJ
City / Town: Monmouth Junction
Country: USA
Postal Code: 08852

Issuer Information

Exchange: NSC
CEO: Phillip P. Chan
Employees: 141
NAICS: Medical Laboratories(621511)

Equities News

Profile

CytoSorbents Corp is a critical care immunotherapy leader commercializing its European Union approved CytoSorb blood purification technology to treat deadly inflammation in critically ill and cardiac surgery patients in around 55 countries.The Company is conducting its pivotal REFRESH 2 - AKI cardiac surgery trial, designed to support U.S. FDA approval. The company's product portfolio consists of CytoSorb, ContrastSorb, VetResQ, HemoDefend, K ontrol, and DrugSorb. The company has around 19 issued U.S. patents, multiple patents issued internationally, and a broad patent application portfolio pending.

Contact Information

Website: www.cytosorbents.com
Email: avogel@cytosorbents.com
Main Phone: +1 732 329-8885
Address: 7 Deer Park Drive
Address 2: Suite K
State: NJ
City / Town: Monmouth Junction
Country: USA
Postal Code: 08852

Issuer Information

Exchange: NSC
CEO: Phillip P. Chan
Employees: 141
NAICS: Medical Laboratories(621511)

Equities News

$ 4.59 $ 0.01 (0.22%)
Last Price 4.59 Change $ 0.01 Change % 0.22 Tick N/A
Bid 4.00 Bid Size 300.00 Ask 5.75 Ask Size 1,000.00
Open 4.55 High 4.66 Low 4.53 Prev Close 4.58
Last Trade Volume 65,778 52 Wk Hi 12.00 52 Wk Low 3.68
Market Cap 148.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 32,303,231.00 EPS (TTM) -0.53 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 26 55
Number of Buys 13 33
Number of Sells 13 22
Net Activity 24785 225628
Last 10 Buys Shares
Michael G. Bator 1,000
Eric R. Mortensen 1,000
Phillip P. Chan 1,000
Edward R. Jones 1,000
Edward R. Jones 1,000
Vincent Capponi 1,000
Phillip P. Chan 1,000
Kathleen P. Bloch 1,000
Phillip P. Chan 1,000
Kathleen P. Bloch 1,000
Last 10 Sell Shares
Vincent Capponi 1,000
Vincent Capponi 1,000
Vincent Capponi 1,000
Vincent Capponi 1,000
Kathleen P. Bloch 1,000
Vincent Capponi 1,000
Kathleen P. Bloch 1,000
Vincent Capponi 1,000
Vincent Capponi 1,000
Kathleen P. Bloch 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 14 14 14 14
Low Target Price Estimate 11 11 11 11
Mean Target Price Estimate 12.6 12.6 12.6 12.6
Standard Deviation 1.14 1.14 1.14 1.14
Date of Most Recent Estimate 05/23/18 05/23/18 05/23/18 05/23/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 4 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1